1-10 of 10
Jennifer Hoek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities

Jan Styczynski, MDPhD, Simona Iacobelli, Peter Donnelly, Gloria Tridello, Jennifer Hoek, Malgorzata Mikulska, Simone Cesaro
Journal: Blood
Blood (2017) 130 (Supplement 1): 3398.
https://doi.org/10.1182/blood.V130.Suppl_1.3398.3398
Published: 2017
Journal Articles

Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

Johannes Schetelig, MD, Patrice Chevallier, MD, Michel Van Gelder, MD PhD, Jennifer Hoek, Olivier Hermine, Ronjon Chakraverty, BMBS, PhD, Paul Browne, MD, Noel Milpied, Michele Malagola, MD, Gerard Socie, MD PhD, Julio Delgado, MD, Eric Deconinck, MD PhD, Gandhi Damaj, MD, Catherine Cordonnier, MD, Dietrich W Beelen, MD PhD, Stephanie Nguyen, MD PhD, Emmanouil Nikolousis, Arne Brecht, MD, Jiri Mayer, Prof, MD SCs, Mathilde Hunault, MD PhD, Jörg Thomas Bittenbring, MD, Catherine Thieblemont, MD PhD, Stéphane Leprêtre, MD, Liesbeth C de Wreede, PhD, Peter Dreger, MD, Nicolaus Kröger
Journal: Blood
Blood (2017) 130 (Supplement 1): 4576.
https://doi.org/10.1182/blood.V130.Suppl_1.4576.4576
Published: 2017
Journal Articles

Use of First or Second Generation TKI for CML after Allogeneic Stem Cell Transplantation: a Study By the CMWP of the EBMT

Yves Chalandon, MD, Simona Iacobelli, Jennifer Hoek, Linda Koster, Liisa Volin, MD PhD, Jürgen Finke, MD, Jan J. Cornelissen, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Charles Craddock, MD PhD, Mahmoud Aljurf, MD MPH, Arnon Nagler, MD, Jakob Passweg, MD, Ellen Meijer, MD PhD, Charles Crawley, MD, Ann Elizabeth Hunter, MD, Boris Afanasyev, MD PhD, Christian Koenecke, MD, Nicolaas P.M. Schaap, MD PhD, Marco R De Groot, MD PhD, Michael Schleuning, MD, Eduardo Olavarria, Nicolaus Kröger
Journal: Blood
Blood (2016) 128 (22): 4685.
https://doi.org/10.1182/blood.V128.22.4685.4685
Published: 2016
Journal Articles

Salvage Use of Ibrutinib after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for B Cell Malignancies: A Study of the French Cooperative Group for CLL, the French Soceity for Blood and Marrow Transplantation (SFGM-TC), and the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancy and Lymphoma Working Parties

Mauricette Michallet, MD PhD, Peter Dreger, MD, Mohamad Sobh, PharmD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Lutz Muller, MD, Paolo Corradini, MD, Wolfgang Bethge, MD, Domenico Russo, MD, Nadira Durakovic, MD PhD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD, Nicolaus Kroger, MD PhD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4659.
https://doi.org/10.1182/blood.V128.22.4659.4659
Published: 2016
Journal Articles

Ibrutinib for Bridging to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Is Safe and Effective: First Results of a Survey By the Chronic Malignancy and the Lymphoma Working Parties of the EBMT

Peter Dreger, MD, Mauricette Michallet, MD PhD, Jennifer Hoek, Data Manager, Ariane Boumendil, PhD, Mohamad Sobh, PharmD, Lutz Muller, MD, Elisabeth A. Vandenberghe, MB, MRCPI, MRCPath, PhD, Ilaria Scortechini, MD, Niels S. Andersen, MD PhD, Jurgen Finke, MD, Domenico Russo, MD, Jakob R Passweg, MD, Helene Schoemans, MD, Nadira Durakovic, MD PhD, Helene Labussiere, MD, Tobias Berg, MD, Dietger Niederwieser, MD, Wolfgang Bethge, MD, Nicola Mordini, MD, Michel van Gelder, MD PhD, Nicolaas PM Schaap, MD PhD, Nicolaus Kroger, MD PhD, Silvia Montoto, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4657.
https://doi.org/10.1182/blood.V128.22.4657.4657
Published: 2016
Journal Articles

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

Eduardo Olavarria, Michael Schleuning, Simona Iacobelli, Jennifer Hoek, Henric-Jan Blok, Mahmoud Aljurf, MD MPH, Boris V Afanasyev, Professor, Liisa Volin, MD PhD, Henrik Sengeloev, MD, Tamás Masszi, Jakob Passweg, MD, Gérard Socié, MD PhD, Paul Browne, MD, Arnold Ganser, MD, Slawomira Kyrcz-Krzemien, Prof, Arnon Nagler, MD MSc, John A Snowden, Harry C. Schouten, Mauricette Michallet, MD PhD, Carmino de Sousa, Theo de Witte, MD PhD, Yves Chalandon, MD, Nicolaus Kröger
Journal: Blood
Blood (2016) 128 (22): 628.
https://doi.org/10.1182/blood.V128.22.628.628
Published: 2016
Journal Articles

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Stefan Schönland, Ute Hegenbart, MD, Simona Iacobelli, Jennifer Hoek, Jakob R. Passweg, MD, Dominique Bordessoule, Jean-Henri Bourhis, MD PhD, Martin R. Schipperus, MD PhD, Theo deWitte, Laurent Garderet, MD, Nicolaus Kröger
Journal: Blood
Blood (2015) 126 (23): 4397.
https://doi.org/10.1182/blood.V126.23.4397.4397
Published: 2015
Journal Articles

Allogeneic HCT in Patients with 17p-CLL: Results of a Non-Interventional Study of the EBMT & Eric

Johannes Schetelig, MD M. Sc,, Jennifer Hoek, Stephan Stilgenbauer, MD, Martin Bornhäuser, MD, Niels S. Andersen, MD, Christopher P Fox, MD, Stig Lenhoff, MD, Donald W. Bunjes, MD, Liisa Volin, MD, Avichai Shimoni, MD, Wilfried A Schroyens, Michel van Gelder, MD, Anja van Biezen, Liesbeth de Wreede, PhD, Theo M de Witte, MD, Nicolaus Kröger, MD, Peter Dreger, MD
Journal: Blood
Blood (2014) 124 (21): 1224.
https://doi.org/10.1182/blood.V124.21.1224.1224
Published: 2014
Journal Articles

Center Experience and Calendar Year Of Transplantation Strongly Influence Short Term Survival After Autologous Peripheral Blood Transplantation In 1315 Patients With Light Chain Amyloidosis: An EBMT Analysis

Stefan O Schonland, MD, Ute Hegenbart, MD, Simona Iacobelli, Ph. D., Jennifer Hoek, M Rovira, Guustaaf van Imhoff, G Bandini, Ulf-Henrik Mellqvist, MD, PhD, Veronique Leblond, MD, Kristina Carlson, Samo Zver, MD, Ph.D, Didier Blaise, MD, Emilio Paolo Alessandrino, MD, Laurent Garderet, Nicolaus Kröger, MD
Journal: Blood
Blood (2013) 122 (21): 417.
https://doi.org/10.1182/blood.V122.21.417.417
Published: 2013
Journal Articles

The Role Of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In Patients With POEMS Syndrome: A Retrospective study Of The Plasma Cell Disorders Subcommittee Of The Chronic Malignancy Working Party Of The EBMT

Gordon Cook, MD, PhD, Laurent Garderet, MD, Simona Iacobelli, Ph. D, Curly Morris, MD, Nikolaus Kroeger, MD, Anja van Biezen, StatAnalyst, M Rovira, Jenny Byrne, Dominique Bordessoule, Giuseppe Leone, M.D., Arnon Nagler, MD, Mark Cook, Laurence Legros, MD, PhD, Gert J. Ossenkoppele, R Gacria Sanz, Jennifer Hoek, Luca Castagna, MD
Journal: Blood
Blood (2013) 122 (21): 415.
https://doi.org/10.1182/blood.V122.21.415.415
Published: 2013